Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Shares Outstanding (Diluted Average) (2019 - 2025)

Historic Shares Outstanding (Diluted Average) for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to $58.7 million.

  • Harmony Biosciences Holdings' Shares Outstanding (Diluted Average) rose 109.18% to $58.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.7 million, marking a year-over-year increase of 109.18%. This contributed to the annual value of $57.9 million for FY2024, which is 414.51% down from last year.
  • Latest data reveals that Harmony Biosciences Holdings reported Shares Outstanding (Diluted Average) of $58.7 million as of Q3 2025, which was up 109.18% from $58.5 million recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' Shares Outstanding (Diluted Average) ranged from a high of $61.2 million in Q1 2023 and a low of $57.6 million during Q2 2024
  • Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $58.8 million (2021), whereas its average is $59.5 million.
  • As far as peak fluctuations go, Harmony Biosciences Holdings' Shares Outstanding (Diluted Average) surged by 65481.71% in 2021, and later plummeted by 591.93% in 2024.
  • Quarter analysis of 5 years shows Harmony Biosciences Holdings' Shares Outstanding (Diluted Average) stood at $59.2 million in 2021, then grew by 3.2% to $61.1 million in 2022, then dropped by 1.19% to $60.4 million in 2023, then dropped by 4.15% to $57.9 million in 2024, then rose by 1.5% to $58.7 million in 2025.
  • Its last three reported values are $58.7 million in Q3 2025, $58.5 million for Q2 2025, and $58.5 million during Q1 2025.